Tinidazole: profile and news

Mission Pharmacal Completes Phase III Study Of Tindamax(R) For The ...  May 9, 2006
...successful completion of a randomized, placebo-controlled, double blind multi-center trial evaluating two dosing regimens of Tindamax(R) (tinidazole) for the ... - Medical News Today (press release),

Mission Pharmacal completes phase III Tindamax study  May 9, 2006
...on results from the trial, Mission Pharmacal plans to file a supplemental new drug application (sNDA) with the FDA for the use of Tindamax (tinidazole) as a ... - Pharmaceutical Business Review

Most Common Curable STD a Significant Public Health Concern When ...  May 9, 2006
Tindamax® (tinidazole tablets) is an FDA-approved, one-day-one-dose treatment for trichomoniasis that has demonstrated cure rates of 92 to 100 percent. ... - Yahoo! News (press release)

(PRN) Mission Pharmacal Acquires Tindamax(R): Treatment for ...  Apr 20, 2006
20 /PRNewswire/ -- Mission Pharmacal today announced that it has acquired the US manufacturing and commercial rights for Tindamax(R) (tinidazole tablets) from ... - Houston Chronicle,

Mission Pharmacal buys rights to STD prescription drug therapy  Apr 21, 2006
Tindamax (tinidazole tables) is a prescription drug therapy primarily for trichomoniasis, the most common non-viral sexually transmitted disease. ... - Bizjournals.com,

New licensing and development agreements.  Apr 26, 2006
Mission Pharmacal (San Antonio, TX, www.missionpharmacal.com) has acquired the US rights to manufacture and commercialize Tindamax (tinidazole) tablets from ... - PharmExec.com,